Selected research
Industry Growth & Trends
Global Radiolabeled Compounds Synthesis Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Radiolabeled Compounds Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Radiolabeled Compounds Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Radiolabeled Compounds Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radiolabeled Compounds Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Radiolabeled Compounds Synthesis Service market include Eurofins, Revvity, Selcia, Labcorp, Pharmaron, WuXi AppTec, AM Chemicals, SEKISUI MEDICAL CO., LTD. and Nuvisan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Radiolabeled Compounds Synthesis Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Radiolabeled Compounds Synthesis Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiolabeled Compounds Synthesis Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiolabeled Compounds Synthesis Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Radiolabeled Compounds Synthesis Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Radiolabeled Compounds Synthesis Service Market by Company
Eurofins
Revvity
Selcia
Labcorp
Pharmaron
WuXi AppTec
AM Chemicals
SEKISUI MEDICAL CO., LTD.
Nuvisan
Almac
Novandi Chemistry
Alfa Cytology
Institute of Isotopes Co. Ltd.
Headway
ViTrax
Radiolabeled Compounds Synthesis Service Segment by Type
Carbon-14 Radiosynthesis Services
Hydrogen-3 Radiosynthesis Services
Chiral Separation and Salt Formation
Others
Radiolabeled Compounds Synthesis Service Segment by Application
Medical Diagnosis and Treatment
Material Science
Nuclear Energy
Others
Radiolabeled Compounds Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiolabeled Compounds Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiolabeled Compounds Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiolabeled Compounds Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Radiolabeled Compounds Synthesis Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Carbon-14 Radiosynthesis Services
- Hydrogen-3 Radiosynthesis Services
- Chiral Separation and Salt Formation
- Others
Applications
- Medical Diagnosis and Treatment
- Material Science
- Nuclear Energy
- Others
Companies covered
- Eurofins
- Revvity
- Selcia
- Labcorp
- Pharmaron
- WuXi AppTec
- AM Chemicals
- SEKISUI MEDICAL CO., LTD.
- Nuvisan
- Almac
- Novandi Chemistry
- Alfa Cytology
- Institute of Isotopes Co. Ltd.
- Headway
- ViTrax
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Radiolabeled Compounds Synthesis Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Radiolabeled Compounds Synthesis Service Market Size by Region (2021-2032)
- 1.4.1 Global Radiolabeled Compounds Synthesis Service Market Size by Region (2021-2026)
- 1.4.2 Global Radiolabeled Compounds Synthesis Service Market Size by Region (2027-2032)
- 1.5 Key Regions Radiolabeled Compounds Synthesis Service Market Size (2021-2032)
- 1.5.1 North America Radiolabeled Compounds Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Radiolabeled Compounds Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Radiolabeled Compounds Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Radiolabeled Compounds Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Radiolabeled Compounds Synthesis Service Market Size Growth Rate (2021-2032)
2 Radiolabeled Compounds Synthesis Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Carbon-14 Radiosynthesis Services
- 2.1.2 Hydrogen-3 Radiosynthesis Services
- 2.1.3 Chiral Separation and Salt Formation
- 2.1.4 Others
- 2.2 Global Radiolabeled Compounds Synthesis Service Market Size by Type
- 2.2.1 Global Radiolabeled Compounds Synthesis Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Radiolabeled Compounds Synthesis Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Radiolabeled Compounds Synthesis Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Radiolabeled Compounds Synthesis Service Market Size by Regions
- 2.3.1 North America Radiolabeled Compounds Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Radiolabeled Compounds Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Radiolabeled Compounds Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Radiolabeled Compounds Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Radiolabeled Compounds Synthesis Service Market Size Breakdown by Type (2021-2026)
3 Radiolabeled Compounds Synthesis Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical Diagnosis and Treatment
- 3.1.2 Material Science
- 3.1.3 Nuclear Energy
- 3.1.4 Others
- 3.2 Global Radiolabeled Compounds Synthesis Service Market Size by Application
- 3.2.1 Global Radiolabeled Compounds Synthesis Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Radiolabeled Compounds Synthesis Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Radiolabeled Compounds Synthesis Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Radiolabeled Compounds Synthesis Service Market Size by Regions
- 3.3.1 North America Radiolabeled Compounds Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Radiolabeled Compounds Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Radiolabeled Compounds Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Radiolabeled Compounds Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Radiolabeled Compounds Synthesis Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Radiolabeled Compounds Synthesis Service Industry Trends
- 4.2 Radiolabeled Compounds Synthesis Service Industry Drivers
- 4.3 Radiolabeled Compounds Synthesis Service Industry Opportunities and Challenges
- 4.4 Radiolabeled Compounds Synthesis Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Radiolabeled Compounds Synthesis Service Revenue (2021-2026)
- 5.2 Global Radiolabeled Compounds Synthesis Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Radiolabeled Compounds Synthesis Service Key Company Headquarters & Area Served
- 5.4 Global Radiolabeled Compounds Synthesis Service Company, Product Type & Application
- 5.5 Global Radiolabeled Compounds Synthesis Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Radiolabeled Compounds Synthesis Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Radiolabeled Compounds Synthesis Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Radiolabeled Compounds Synthesis Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eurofins
- 6.1.1 Eurofins Company Information
- 6.1.2 Eurofins Business Overview
- 6.1.3 Eurofins Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eurofins Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.1.5 Eurofins Recent Developments
- 6.2 Revvity
- 6.2.1 Revvity Company Information
- 6.2.2 Revvity Business Overview
- 6.2.3 Revvity Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Revvity Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.2.5 Revvity Recent Developments
- 6.3 Selcia
- 6.3.1 Selcia Company Information
- 6.3.2 Selcia Business Overview
- 6.3.3 Selcia Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Selcia Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.3.5 Selcia Recent Developments
- 6.4 Labcorp
- 6.4.1 Labcorp Company Information
- 6.4.2 Labcorp Business Overview
- 6.4.3 Labcorp Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Labcorp Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.4.5 Labcorp Recent Developments
- 6.5 Pharmaron
- 6.5.1 Pharmaron Company Information
- 6.5.2 Pharmaron Business Overview
- 6.5.3 Pharmaron Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pharmaron Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.5.5 Pharmaron Recent Developments
- 6.6 WuXi AppTec
- 6.6.1 WuXi AppTec Company Information
- 6.6.2 WuXi AppTec Business Overview
- 6.6.3 WuXi AppTec Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 WuXi AppTec Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.6.5 WuXi AppTec Recent Developments
- 6.7 AM Chemicals
- 6.7.1 AM Chemicals Company Information
- 6.7.2 AM Chemicals Business Overview
- 6.7.3 AM Chemicals Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 AM Chemicals Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.7.5 AM Chemicals Recent Developments
- 6.8 SEKISUI MEDICAL CO., LTD.
- 6.8.1 SEKISUI MEDICAL CO., LTD. Company Information
- 6.8.2 SEKISUI MEDICAL CO., LTD. Business Overview
- 6.8.3 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.8.5 SEKISUI MEDICAL CO., LTD. Recent Developments
- 6.9 Nuvisan
- 6.9.1 Nuvisan Company Information
- 6.9.2 Nuvisan Business Overview
- 6.9.3 Nuvisan Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Nuvisan Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.9.5 Nuvisan Recent Developments
- 6.10 Almac
- 6.10.1 Almac Company Information
- 6.10.2 Almac Business Overview
- 6.10.3 Almac Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Almac Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.10.5 Almac Recent Developments
- 6.11 Novandi Chemistry
- 6.11.1 Novandi Chemistry Company Information
- 6.11.2 Novandi Chemistry Business Overview
- 6.11.3 Novandi Chemistry Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Novandi Chemistry Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.11.5 Novandi Chemistry Recent Developments
- 6.12 Alfa Cytology
- 6.12.1 Alfa Cytology Company Information
- 6.12.2 Alfa Cytology Business Overview
- 6.12.3 Alfa Cytology Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Alfa Cytology Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.12.5 Alfa Cytology Recent Developments
- 6.13 Institute of Isotopes Co. Ltd.
- 6.13.1 Institute of Isotopes Co. Ltd. Company Information
- 6.13.2 Institute of Isotopes Co. Ltd. Business Overview
- 6.13.3 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.13.5 Institute of Isotopes Co. Ltd. Recent Developments
- 6.14 Headway
- 6.14.1 Headway Company Information
- 6.14.2 Headway Business Overview
- 6.14.3 Headway Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Headway Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.14.5 Headway Recent Developments
- 6.15 ViTrax
- 6.15.1 ViTrax Company Information
- 6.15.2 ViTrax Business Overview
- 6.15.3 ViTrax Radiolabeled Compounds Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 ViTrax Radiolabeled Compounds Synthesis Service Product Portfolio
- 6.15.5 ViTrax Recent Developments
7 North America
- 7.1 North America Radiolabeled Compounds Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Radiolabeled Compounds Synthesis Service Market Size by Country (2021-2026)
- 7.3 North America Radiolabeled Compounds Synthesis Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Radiolabeled Compounds Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Radiolabeled Compounds Synthesis Service Market Size by Country (2021-2026)
- 8.3 Europe Radiolabeled Compounds Synthesis Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Radiolabeled Compounds Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Radiolabeled Compounds Synthesis Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Radiolabeled Compounds Synthesis Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Radiolabeled Compounds Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Radiolabeled Compounds Synthesis Service Market Size by Country (2021-2026)
- 10.3 South America Radiolabeled Compounds Synthesis Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Radiolabeled Compounds Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Radiolabeled Compounds Synthesis Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Radiolabeled Compounds Synthesis Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst